Last quarter (Q3 2023), HAVN Life Sciences's total revenue was C$57.92K, an increase of 151.54% from the same quarter last year. In Q3, HAVN Life Sciences's net income was C$-665.73K. See HAVN Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 22	Apr 21	Apr 20
Total Revenue	C$ 971.70K	C$ 552.95K	-	C$ 0.00
Cost of Revenue	C$ 491.28K	C$ 373.56K	-	-
Gross Profit	C$ 480.42K	C$ 179.39K	-	-
Operating Expense	C$ 6.23M	C$ 19.80M	C$ 24.35M	C$ 41.12K
Operating Income	C$ -5.75M	C$ -19.62M	C$ -24.35M	C$ -41.12K
Net Non Operating Interest Income Expense	C$ 379.00	C$ -68.29K	C$ 17.50K	C$ 548.00
Other Income Expense	C$ -11.93M	-	C$ -6.02M	-
Pretax Income	C$ -20.89M	C$ -44.89M	C$ -30.38M	C$ -40.58K
Tax Provision	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	C$ -20.89M	C$ -44.89M	C$ -30.38M	C$ -40.58K
Basic EPS	C$ -0.89	C$ -10.50	C$ -468.00	C$ >-0.01
Diluted EPS	C$ -0.89	C$ -10.50	C$ -468.00	C$ >-0.01
Basic Average Shares	C$ 21.86M	C$ 8.56M	C$ 65.49K	C$ 66.97M
Diluted Average Shares	C$ 21.86M	C$ 8.56M	C$ 65.49K	C$ 66.97M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	C$ 43.61K	-	-	C$ 0.00
Total Expenses	C$ 6.72M	C$ 20.17M	C$ -24.35M	C$ 41.12K
Net Income From Continuing And Discontinued Operation	C$ -20.89M	C$ -44.89M	C$ -30.38M	C$ -40.58K
Normalized Income	C$ -4.95M	C$ -7.84M	C$ -22.24M	C$ -40.58K
Interest Expense	C$ 29.63K	-	-	C$ 0.00
EBIT	C$ -20.86M	C$ -44.76M	C$ -30.36M	C$ -40.58K
EBITDA	C$ -20.72M	C$ -43.61M	C$ -25.76M	C$ -40.58K

Currency in CAD

HAVN Life Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing